- Study conducted with The University of Manchester – UK.
- MEBO Scar found to improve skin hydration, collagen deposition, and elasticity
February 6th, 2019, Ras Al Khaimah (UAE) – Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has had a groundbreaking paper published in “Advances of Wound Care Journal”, the Official Publication of the Wound Healing Society.
The paper provides fresh insights into the positive effects of Julphar’s ointment, MEBO Scar, in managing scars. MEBO Scar is one of Julphar’s leading products and is made from natural ingredients including sesame, cactus and beeswax, which are thought to improve the appearance of scars.
The study included 45 volunteers, whom were given MEBO Scar as well a widely used anti-scarring topical, which was used as the control for the research. The culmination of three years’ work, found that MEBO Scar improved skin hydration, collagen deposition, and elasticity; things that are vital for scars quality. The research was jointly conducted by Julphar and the University of Manchester in the UK.
“Many topicals promise rapid and effective results but there is limited evidence to support their effectiveness in skin scar management. Cosmetic products were tested on animals up until March 2013, when the European Union prohibited the sale of such products. Aside from the ethical issues surrounding animal testing, the results were not accurate due to the differences between human and animal skin. In addition, in many human skin clinical trials, the evidence is poor.” said Dr. Al Kredly – The Head of Medical Affairs in Julphar.
“We looked at things like hydration, blood flow through the scar, the color of the scar and the amount of collagen, the protein of which scar tissue is composed. What we found was that from the moment the ointment was applied, right up until week 12, there was a significant change in hydration, elasticity, collagen deposition, discoloration, and blood flow which was exactly the kind of evidence we were looking for.” added Dr. Al Kredly.